Twitter Stock Spikes as Musk Wants to Buy Twitter at Original Offer…What’s Your Next Move?
In the never-ending saga of Musk vs Twitter, it appears the eccentric billionaire is back with another proposal. This time? The original offer price of $54.20/share. Down below, we’ll highlight the details of what we know so far and what you should do from an investment standpoint. This deal leads to a valuation of $44 billion for Twitter. Originally, [...]
Viasat’s Deal Repositions to Compete with SpaceX – But is This Reason Enough to Buy VSAT Stock Now?
Viasat, a satellite broadband communications company for the military and commercial markets, enjoyed a 40% boost in stock price Monday morning. This spike resulted from their deal with defense contractor L3 Harris Technologies. In total, the deal is estimated to bring in over $1.8 billion after taxes, fees, and other expenses. The deal will result in Viasat selling its [...]
Nike Stock Falls as Margins Drop & Inventory Grows…Should You Weather the Storm or Sell Now?
Nike stock plunged 12% this morning after another earnings report that missed expectations. While revenue and EPS figures came in strong, the margins slipped up a bit - which has only been exacerbated by inflation. But the real reason analysts and investors alike have growing concern over the trajectory of Nike? Inventory. Their inventory is up 44% - with [...]
A Dwindling Pandemic Spells Disaster for Rite Aid Stock…could it get even worse?
While Rite Aid had a good run during the pandemic, it appears the stock is headed back towards the bottom - as the company reports another quarter of poor results. The retail drug store chain lost over $300 million in the fiscal 2nd quarter. This resulted in a net loss per share of $6.07, way up from the previous [...]
Cheniere Energy Powers Ahead in the Liquefied Natural Gas Market
On Thursday, September 28, LNG had a huge up day with a $10.60 gain (6.95%) after hitting an intraday low of $147.70 on September 26. The high for the year was on September 14 at $178.62. The closing price pierced its 50-day moving average and closed well above it. Over the past year, energy-related stocks have been the leading [...]
What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock
Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. And [...]
